Ginkgo Bioworks Holdings, Inc.
DNA
Key stats
- Open
- 10.00
- Day high
- 10.48
- Day low
- 9.53
- Previous close
- 10.25
- Volume
- 2.50M
- VWAP
- 10.07
- 52-week high
- 18.22
- 52-week low
- 5.37
- Market cap
- 664.46M
- Shares out
- 55.38M
- Employees
- 485
- Listed
- 2021
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · BOSTON, MA · ginkgobioworks.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 2.8K
- Put open interest
- 941
- Put/call
- 0.34
- At-the-money IV
- 109.5%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 9 put | 0.15 | Nov 12, 3:47 PM | 84 | 118 | 112.9% |
| 11 call | 0.45 | Nov 12, 1:50 PM | 77 | 1.1K | 106.4% |
| 12 call | 0.25 | Nov 11, 3:54 PM | 64 | 616 | 120.4% |
| 10 call | 0.80 | Nov 12, 1:17 PM | 58 | 246 | 109.5% |
| 13 call | 0.10 | Nov 12, 12:46 PM | 27 | 631 | 125.9% |
| 9 call | 1.25 | Nov 12, 10:06 AM | 10 | 56 | 123.9% |
Quarterly results
Massive · Aug 6, 2026| Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | Q3 2025 to Sep 30, 2025 | |
|---|---|---|---|---|
| Revenue | $20.16M | $19.47M | $33.40M | $38.84M |
| Gross profit | $18.44M | $16.38M | $26.09M | $26.04M |
| Operating income | −$58.55M | −$78.52M | −$70.75M | −$90.02M |
| Net income | −$46.71M | −$82.59M | −$80.75M | −$80.75M |
| Diluted EPS | -0.75 | -1.39 | -1.41 | -1.45 |
| Operating cash flow | −$44.27M | −$46.69M | −$47.68M | −$31.61M |
| Assets | $990.05M | $1.03B | $1.12B | $1.19B |
| Liabilities | $569.76M | $589.92M | $611.11M | $629.38M |
| Equity | $420.28M | $443.15M | $508.59M | $559.78M |
Technicals
Massive · Nov 12, 2026- 50-day average10.24
- 200-day average8.64
- RSI (14 days)47.1
Short interest
Massive · Oct 30, 2026- Oct 30, 20269.49M shares · 3.9 days to cover
- Oct 15, 20268.29M shares · 1.9 days to cover
- Sep 30, 20267.32M shares · 2.7 days to cover
- Sep 15, 20267.17M shares · 7.2 days to cover
Splits
Massive · Aug 20, 2024- Aug 20, 20241-for-40
Related companies
MassiveNews coverage
No stories about Ginkgo Bioworks Holdings, Inc. right now.